Matthew L. Kaplan - 08 Feb 2022 Form 3 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Director
Signature
/s/ Matthew Kaplan
Issuer symbol
NVCT
Transactions as of
08 Feb 2022
Net transactions value
$0
Form type
3
Filing time
08 Feb 2022, 07:32:35 UTC
Next filing
05 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NVCT Common Stock 32,760 08 Feb 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NVCT Options 08 Feb 2022 Common stock 9,750 $3.05 Direct
holding NVCT Options 08 Feb 2022 Common stock 9,750 $3.05 Direct
holding NVCT Options 08 Feb 2022 Common stock 9,750 $3.05 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.